The Federal Trade Commission and the Department of Health and Human Services are working together to investigate whether the practices of pharmaceutical middlemen are contributing to generic drug shortages across the healthcare sector.

“When you’re prescribed an important medication by your doctor and you learn the drug is out of stock, your heart sinks,” HHS Secretary Xavier Becerra said. “Today’s initiative is just one more action by HHS to best address shortages of generic drugs.”